2.75
price down icon0.36%   -0.010
 
loading
前日終値:
$2.76
開ける:
$2.77
24時間の取引高:
28,744
Relative Volume:
0.16
時価総額:
$93.05M
収益:
-
当期純損益:
$-13.27M
株価収益率:
-16.77
EPS:
-0.164
ネットキャッシュフロー:
$-7.70M
1週間 パフォーマンス:
-8.03%
1か月 パフォーマンス:
+11.34%
6か月 パフォーマンス:
+161.90%
1年 パフォーマンス:
+103.70%
1日の値動き範囲:
Value
$2.70
$2.7816
1週間の範囲:
Value
$2.67
$2.9803
52週間の値動き範囲:
Value
$0.8075
$3.11

Okyo Pharma Limited Stock (OKYO) Company Profile

Name
名前
Okyo Pharma Limited
Name
セクター
Healthcare (1164)
Name
電話
-
Name
住所
-
Name
職員
4
Name
Twitter
Name
次回の収益日
2024-09-30
Name
最新のSEC提出書
Name
OKYO's Discussions on Twitter

OKYO を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
OKYO
Okyo Pharma Limited
2.75 103.81M 0 -13.27M -7.70M -0.164
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
469.65 121.28B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
563.10 60.96B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
328.81 42.77B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
591.99 36.21B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
291.47 32.08B 3.81B -644.79M -669.77M -6.24

Okyo Pharma Limited (OKYO) 最新ニュース

pulisher
11:31 AM

What is the risk reward ratio of investing in OKYO Pharma Limited stockInvest smarter with real-time trading alerts - jammulinksnews.com

11:31 AM
pulisher
09:48 AM

Published on: 2025-07-27 19:17:36 - jammulinksnews.com

09:48 AM
pulisher
08:24 AM

How Resilient Is OKYO Pharma Limited Stock During Economic DownturnsFast Moving Stock Alerts - Newser

08:24 AM
pulisher
07:18 AM

What catalysts could drive OKYO Pharma Limited stock higher in 2025Discover stocks with massive upside potential - jammulinksnews.com

07:18 AM
pulisher
05:18 AM

Why OKYO Pharma Limited stock attracts strong analyst attentionMarket Beating Strategy - Newser

05:18 AM
pulisher
02:20 AM

How OKYO Pharma Limited stock performs during market volatilityControlled Risk High Reward Plan - Newser

02:20 AM
pulisher
Jul 25, 2025

OKYO Pharma Limited Stock Analysis and ForecastMarket-beating returns - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

What analysts say about OKYO Pharma Limited stockMassive stock growth - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

What institutions are buying OKYO Pharma Limited stock nowFree Market Dynamics Reports - jammulinksnews.com

Jul 25, 2025
pulisher
Jul 25, 2025

Will OKYO Pharma Limited stock benefit from AI tech trendsExplosive market performance - jammulinksnews.com

Jul 25, 2025
pulisher
Jul 24, 2025

OKYO Pharma reports promising phase 2 results for urcosimod in neuropathic corneal pain - Pharmafile

Jul 24, 2025
pulisher
Jul 23, 2025

What drives OKYO Pharma Limited stock priceAccelerated wealth expansion - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

Is OKYO Pharma Limited a good long term investmentPhenomenal trading returns - Autocar Professional

Jul 23, 2025
pulisher
Jul 21, 2025

OKYO Pharma Secures $1.9 Million in Non-Dilutive Funding to Accelerate Development of Urcosimod for Neuropathic Corneal Pain - VisionMonday.com

Jul 21, 2025
pulisher
Jul 19, 2025

OKYO Pharma CEO details positive results from Phase 2 urcosimod trialICYMI - Proactive financial news

Jul 19, 2025
pulisher
Jul 18, 2025

OKYO Pharma Secures $1.9M Non-Dilutive Funding to Advance Urcosimod Development - AInvest

Jul 18, 2025
pulisher
Jul 18, 2025

OKYO Pharma announces positive results from phase 2 trial of urcosimod for neuropathic corneal pain - Ophthalmology Times

Jul 18, 2025
pulisher
Jul 18, 2025

Small cap wrap: Digi Power X, American Resources, OKYO Pharma, Lisata Therapeutics... - Proactive financial news

Jul 18, 2025
pulisher
Jul 17, 2025

OKYO Pharma Receives $1.9 Million in Non-Dilutive Funding - GlobeNewswire

Jul 17, 2025
pulisher
Jul 17, 2025

OKYO Pharma receives $1.9 million non-dilutive funding for lead drug development - Investing.com Nigeria

Jul 17, 2025
pulisher
Jul 17, 2025

OKYO Slides Despite Fresh R&D Funding - Baystreet.ca

Jul 17, 2025
pulisher
Jul 17, 2025

OKYO Pharma secures $1.9 million in non-dilutive funding for eye drug - Investing.com Canada

Jul 17, 2025
pulisher
Jul 17, 2025

Okyo Pharma Obtains $1.9 Million Non-Dilutive Funding - MarketScreener

Jul 17, 2025
pulisher
Jul 17, 2025

OKYO Pharma Secures $1.9 Million to Boost Urcosimod Development - TipRanks

Jul 17, 2025
pulisher
Jul 17, 2025

OKYO Pharma bolsters ocular pain program with $1.9M non-dilutive financing - Proactive financial news

Jul 17, 2025

Okyo Pharma Limited (OKYO) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$23.40
price down icon 0.97%
$36.67
price up icon 0.22%
$103.95
price up icon 0.42%
$28.67
price up icon 3.99%
$115.31
price up icon 0.65%
biotechnology ONC
$291.47
price down icon 1.68%
大文字化:     |  ボリューム (24 時間):